Fact CheckerSign in

NCT06920290Active, not recruiting

Visual Field Analysis With Artificial Intelligence

Visual Field Analysis With Artificial Intelligence: Establishing Normal Threshold Values for Healthy Participants Using a Visual Field Perimeter

Source: ClinicalTrials.gov · Last updated 3 Nov 2025

Brief summary (registry, in English)

The purpose of this study is to analyze visual field data from healthy participants. This data will be used to develop and optimize a new visual field perimeter test. The test will incorporate an advanced algorithm, which may include the use of Artificial Intelligence (AI), to enhance accuracy and efficiency in identifying test points.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
100 (estimated)
First submitted
27 Mar 2025
Start date
Jul 2025
Primary completion date
Aug 2026
Lead sponsor
Sight Intelligence Engineering Corporation
Diseases
Glaucoma
NCT number
NCT06920290

What you commit to

  • Study type: Observational
  • Planned participants: 100
  • From Jul 2025 to the primary completion date, Aug 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previously documented glaucoma or optic neuropathy.

Other illness

  • Any significant ocular or neurological condition that may impact visual field.

Other

  • Best corrected visual acuity worse than 20/40.
  • Cup-to-disc ratio greater than 0.5.
  • Inability to comply with study procedures.

Who the study is looking for

  • Healthy adults aged 18 years or older.
  • Best corrected visual acuity of 20/40 or better in each eye.
  • Normal optic nerve appearance upon clinical examination.

Age in the registry: 18 years to 100 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sight Intelligence Engineering
Coordinator of this site? Confirm its status
AlexandriaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.